![]() |
市場調查報告書
商品編碼
1831002
超低溫冷凍機市場Ultra-Low Temperature Freezer Market |
超低溫冷凍機市場預計將從 2024 年的 7.2436 億美元成長至 2031 年的 11.0428 億美元,2025 年至 2031 年的複合年成長率預計為 4.8%。
市場洞察與分析師觀點:超低溫冰箱市場持續成長,得益於新藥研發力度的加大、血液及血液成分需求的不斷成長以及政府對研究和臨床試驗的支持力度的加大。此外,市場參與者不斷推出先進產品,也推動了市場擴張。賽默飛世爾科技 Revco RLE -86°C 直立式冰箱提供五種容量,可容納 300 至 700 個 2 英吋(約 5 公分)的冷凍盒,並提供卓越的熱性能、安全性和保障性。
成長動力與挑戰:生物研究樣本需要在-80°C以下的溫度下儲存,而超低溫 (ULT) 正是為此而生。 ULT 功能可取代傳統的壓縮機冷卻技術,隨著人們對其理解的不斷深入,該技術也在不斷改進。海爾生物醫療的創新 ULT 冰箱採用智慧變頻技術,能耗僅 8.2 千瓦時/天,容量高達 829 公升/29.2 立方英尺。 2022 年 10 月,賽默飛世爾科技在其超低溫 (ULT) 綠色產品組合中推出了一款新型冰箱——賽默飛世爾科技在其超低溫 (ULT) 綠色產品組合中推出了一款新型冰箱——賽默飛世爾 TDE 系列 -80°C 臥式冷凍櫃,該冰箱由 H-drive 碳氫化合物系統驅動,在提升關鍵研究性能的同時,保持了永續發展目標。 2023 年 6 月,BioLife Solutions 的 Stirling 超冷立式 ULT 冰箱 ISO 6 級獲得無塵室應用認證,符合良好生產規範 (GMP) 標準,確保生物儲存性能和環境清潔度。
超低溫樣本儲存冰箱是全球眾多生物樣本庫、診所和實驗室的必備設備,可用於保存各種生物樣本,包括 DNA、RNA、蛋白質和細胞萃取物。維持低溫需要持續供電。國際永續實驗室研究所報告稱,超低溫冰箱平均每日耗電量約 20 千瓦時,相當於一戶家庭的用電量。鑑於實驗室和研究機構通常同時運作多台設備,相關的運作成本和能源成本會顯著影響使用者偏好。立式機械超低溫冰箱的年運行成本在 750 美元(570 英鎊)到 1,000 美元(750 英鎊)之間,具體取決於尺寸和溫度範圍等因素。定期維護(包括除霜)可以顯著降低這些成本。此外,上述數字尚未計算與暖通空調系統和暖風去除相關的額外費用,因此,對於注重預算的實驗室和儲存機構來說,超低溫冰箱的高成本是一個主要問題。
戰略洞察
報告細分和範圍:超低溫冷凍機市場按類型、應用、技術和地理分類。依應用,市場分為血液和血液製品、器官、藥品、法醫和基因組研究等。依技術細分,市場分為全自動和半自動兩大類。
從地理上看,超低溫冷凍機市場分為北美(美國、加拿大和墨西哥)、歐洲(英國、德國、法國、義大利、西班牙、俄羅斯和歐洲其他地區)、亞太地區(中國、日本、印度、韓國、澳洲、東南亞和亞太其他地區)、中東和非洲(阿拉伯聯合大公國、沙烏地阿拉伯、南非和中東和非洲其他地區)以及南美洲和中美洲(巴西、阿根廷和中美洲(巴西和南美洲)。
細分分析:超低溫冷凍櫃市場分為臥式冷凍櫃和立式冷凍櫃。 2022年,立式冷凍櫃佔據了更大的市場佔有率,預計2022年至2030年期間的複合年成長率將更高。立式冷凍櫃的預期成長歸因於其緊湊的設計、易於整理和多種安全功能等優勢。此外,由於技術進步增強了操作監督和便利性,其採用率不斷提高,這將在預測期內進一步推動立式冷凍櫃的成長。
區域分析:按區域分類,超低溫冷凍櫃市場分為北美、歐洲、亞太、中東和非洲以及南美和中美。北美是全球超低溫冷凍櫃市場成長的最大貢獻者。預計2022年至2030年,亞太地區將在超低溫冷凍櫃市場達到最高的複合年成長率。美國超低溫冷凍櫃市場的成長主要受肺癌發病率上升、新產品發布和政府措施的推動。對生物樣本庫日益成長的需求正在改變美國的醫療保健和經濟體系,重點是了解疾病、藥物發現和發展。此外,生物樣本庫研究為人類疾病的遺傳方面提供了新的見解,從而帶來了更自動化和個人化的醫療保健方法。美國的一些市場參與者致力於提供多樣化和創新的生物樣本庫產品和服務組合,旨在加速拯救生命的發現。市場參與者之間日益成長的業務活動對市場成長做出了重大貢獻。 2020 年 11 月,儘管美國疾病管制與預防中心 (CDC) 指導推遲購買,但美國各州的醫院在採購安全儲存輝瑞公司 COVID-19 疫苗所需的超低溫冰箱方面仍面臨挑戰。
超低溫冷凍機市場報告範圍
產業發展與未來機會:超低溫冷凍機市場領導者的主要措施包括:
2023年5月,北美PHC公司(PHCNA)宣布,其PHCbi品牌VIP ECO SMART超低溫冰箱榮獲國際生物與環境資源庫協會(ISBER)頒發的2023年度傑出新產品獎。本產品適用於大學、醫療機構、製藥公司等各類場所。
2023年2月,PHC北美公司(PHCNA)推出PHCbi品牌VIP ECO SMART超低溫冷凍機系列,該系列以創新可靠的技術為基礎,在提升節能性能的同時,提高了安全性和可用性。
競爭格局與主要公司:超低溫冷凍機市場的知名企業包括賽默飛世爾科技公司、Godrej集團、海爾集團、藍星有限公司、Helmer Scientific公司、PHC Holdings、BioLife Solutions公司、Eppendorf SE、Meling Biomedical和Arctiko。這些公司專注於推出新產品並進行地理擴張,以滿足日益成長的全球消費者需求,並擴大其特色產品供應。其國際影響力使其能夠服務龐大的客戶群,從而促進市場擴張。
The ultra-low temperature freezer market is projected to increase from US$ 724.36 million in 2024 to US$ 1,104.28 million by 2031, with an expected CAGR of 4.8% from 2025 to 2031.
Market Insights and Analyst View:The ultra-low temperature freezer market is growing due to heightened R&D efforts aimed at developing new drug compounds, a rising demand for blood and blood components, and increased government backing for research and clinical trials. Furthermore, the introduction of advanced products by market players is propelling market expansion. Thermo Scientific Revco RLE -86°C upright freezers come in five capacities, accommodating 300 to 700 2-inch boxes, and offer exceptional thermal performance, safety, and security.
Growth Drivers and Challenges:Biological research specimens require storage at temperatures below -80°C, which is where ultra-low temperature (ULT) values come into play. The ULT feature serves as an alternative to traditional compressor-based cooling technology, which continues to improve as understanding of it advances. Haier Biomedical's innovative ULT freezers utilize smart frequency conversion technology, achieving an impressive energy consumption rate of just 8.2 Kwhr/day with a capacity of 829 L/29.2 ft3. In October 2022, Thermo Fisher Scientific introduced a new freezer to its ultra-low temperature (ULT) green portfolio, the Thermo Scientific TDE Series -80°C Chest Freezer, which is powered by H-drive hydrocarbon systems, enhancing performance for critical research while maintaining sustainability goals. In June 2023, BioLife Solutions' Stirling ultracold upright ULT freezer ISO class 6 received approval for cleanroom applications in line with Good Manufacturing Practice (GMP) standards, ensuring biostorage performance and environmental cleanliness.
ULT sample storage freezers are essential for numerous biobanks, clinics, and laboratories worldwide, allowing for the preservation of various biological samples, including DNA, RNA, proteins, and cell extracts. A constant power supply is necessary to sustain low temperatures. The International Institute for Sustainable Laboratories reports that the average ULT freezer consumes approximately 20 kWh per day, equivalent to the energy usage of a single-family home. Given that laboratories and research facilities often operate multiple units simultaneously, the associated operating and energy costs can significantly influence user preferences. The annual operating cost for an upright, mechanical ULT freezer can range from US$ 750 (£570) to US$ 1,000 (£750), depending on factors such as size and temperature range. Regular maintenance, including defrosting, can substantially lower these costs. Additionally, the aforementioned figures do not account for the extra expenses related to HVAC systems and warm air removal, making the high costs of ULT freezers a major concern for budget-conscious laboratories and storage facilities.
Strategic Insights
Report Segmentation and Scope:The ultra-low temperature freezer market is categorized by type, application, technology, and geography. By application, the market is divided into blood and blood products, organs, pharmaceuticals, forensic and genomic research, and others. The technology segment is split into automatic and semi-automatic categories.
Geographically, the ultra-low temperature freezer market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, Southeast Asia, and the Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Segmental Analysis:The ultra-low temperature freezer market is divided into chest freezers and upright freezers. In 2022, the upright freezer segment held a larger market share and is expected to experience a higher CAGR from 2022 to 2030. The anticipated growth in the upright freezer segment is attributed to benefits such as compact design, ease of organization, and a variety of safety features. Additionally, the increasing adoption rate due to technological advancements that enhance operational supervision and convenience will further boost the growth of the upright segment during the forecast period.
Regional Analysis:Regionally, the ultra-low temperature freezer market is divided into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is the largest contributor to the global ultra-low temperature freezer market growth. Asia Pacific is anticipated to achieve the highest CAGR in the ultra-low temperature freezer market from 2022 to 2030. The growth of the ultra-low temperature freezer market in the US is primarily driven by the rising prevalence of lung cancer, new product launches, and government initiatives. The increasing demand for biobanks is transforming the healthcare and economic systems in the US, with a focus on understanding diseases, drug discovery, and development. Furthermore, biobank research is providing new insights into the genetic aspects of human diseases, leading to a more automated and personalized healthcare approach. Several market players in the US are dedicated to offering a diverse and innovative portfolio of biobanking products and services aimed at accelerating lifesaving discoveries. The growing number of business activities among market players is significantly contributing to market growth. In November 2020, hospitals across various US states faced challenges in acquiring ultra-cold freezers necessary for the safe storage of the Pfizer Inc. COVID-19 vaccine, despite guidance from the US Centers for Disease Control and Prevention (CDC) to delay purchases.
Ultra-Low Temperature Freezer Market Report Scope
Industry Developments and Future Opportunities:Key initiatives by leading players in the ultra-low temperature freezer market include:
In May 2023, PHC Corporation of North America (PHCNA) announced that its PHCbi brand VIP ECO SMART ultra-low temperature freezer received the Outstanding New Product Award for 2023 from the International Society for Biological and Environmental Repositories (ISBER). This product is designed for use in various facilities, including universities, medical institutions, and pharmaceutical companies.
In February 2023, PHC Corporation of North America (PHCNA) launched the PHCbi brand VIP ECO SMART ultra-low temperature freezer series, which is built on innovative and reliable technology to enhance energy-saving performance while improving security and usability.
Competitive Landscape and Key Companies:Prominent players in the ultra-low temperature freezer market include Thermo Fisher Scientific Inc, Godrej Group, Haier Group Corporation, Blue Star Limited, Helmer Scientific Inc, PHC Holdings, BioLife Solutions Inc, Eppendorf SE, Meling Biomedical, and Arctiko. These companies are focused on launching new products and expanding geographically to meet the growing global consumer demand and broaden their specialty product offerings. Their international presence enables them to serve a large customer base, facilitating market expansion.